Race
Visit number vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
Follow-up | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 178 | 301 |
Treatment Arm vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 53 | 19.9 | ± 5.1 | 19.2 | 11.6 | 36.2 | 53 | 106 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 60 | 20.3 | ± 5.3 | 19.9 | 11.6 | 38.2 | 46 | 106 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 50 | 21.1 | ± 6.8 | 20.6 | 10.2 | 38.0 | 56 | 106 |
Treatment Arm vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 178 | 301 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 48 | 19.1 | ± 6.8 | 16.2 | 10.9 | 37.8 | 52 | 100 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 38 | 19.7 | ± 6.1 | 18.5 | 10.7 | 36.0 | 63 | 101 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 37 | 18.9 | ± 5.8 | 18.3 | 10.7 | 34.4 | 63 | 100 |
Age category vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
45-54 years | 23 | 18.9 | ± 5.1 | 17.5 | 11.2 | 27.0 | 30 | 53 |
55-64 years | 61 | 19.2 | ± 5.3 | 18.5 | 10.2 | 34.2 | 78 | 139 |
65 years or older | 79 | 21.7 | ± 6.0 | 21.3 | 11.8 | 38.2 | 47 | 126 |
Age category vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 177 | 300 |
45-54 years | 25 | 16.6 | ± 5.6 | 15.0 | 10.7 | 30.9 | 24 | 49 |
55-64 years | 46 | 18.2 | ± 5.8 | 17.1 | 10.9 | 36.0 | 81 | 127 |
65 years or older | 52 | 21.4 | ± 6.4 | 20.4 | 10.7 | 37.8 | 72 | 124 |
Gender of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
Female | 42 | 18.4 | ± 5.3 | 17.7 | 10.2 | 38.2 | 42 | 84 |
Male | 121 | 21.1 | ± 5.8 | 20.3 | 11.4 | 38.0 | 113 | 234 |
Gender of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 178 | 301 |
Female | 23 | 16.2 | ± 4.0 | 15.0 | 11.6 | 24.3 | 56 | 79 |
Male | 100 | 19.9 | ± 6.5 | 18.5 | 10.7 | 37.8 | 122 | 222 |
Race of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 162 | 20.4 | ± 5.8 | 19.8 | 10.2 | 38.2 | 155 | 317 |
White | 133 | 20.8 | ± 5.7 | 20.1 | 10.2 | 38.0 | 123 | 256 |
American Indian or Alaskan Native | 1 | 17.5 | - | 17.5 | 17.5 | 17.5 | 1 | 2 |
Black or African American | 20 | 20.0 | ± 6.1 | 19.9 | 13.9 | 38.2 | 23 | 43 |
Asian | 2 | 19.1 | ± 7.0 | 19.1 | 14.1 | 24.0 | 4 | 6 |
Native Hawaiian or other Pacific islander | 1 | 17.5 | - | 17.5 | 17.5 | 17.5 | - | 1 |
Other | 2 | 18.5 | ± 2.1 | 18.5 | 17.0 | 19.9 | 2 | 4 |
Multiple | 3 | 11.7 | ± 0.6 | 11.6 | 11.2 | 12.3 | 2 | 5 |
Race of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 122 | 19.2 | ± 6.3 | 17.8 | 10.7 | 37.8 | 177 | 299 |
White | 102 | 19.6 | ± 6.6 | 18.2 | 10.7 | 37.8 | 139 | 241 |
American Indian or Alaskan Native | 1 | 15.6 | - | 15.6 | 15.6 | 15.6 | 1 | 2 |
Black or African American | 12 | 18.4 | ± 5.0 | 17.8 | 13.0 | 29.6 | 29 | 41 |
Asian | 5 | 16.6 | ± 4.1 | 15.9 | 12.5 | 21.3 | 1 | 6 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | 1 | 1 |
Other | 1 | 15.1 | - | 15.1 | 15.1 | 15.1 | 2 | 3 |
Multiple | 1 | 16.1 | - | 16.1 | 16.1 | 16.1 | 4 | 5 |